Teresa Regan
Human Resources Officer chez NEON THERAPEUTICS, INC.
Profil
Teresa Regan is currently the Chief People & Culture Officer at BioNTech US, Inc. She previously worked as the Head of Human Resources at Cubist Pharmaceuticals LLC from 1997 to 2004 and as the Vice President of Human Resources at Tolerx, Inc. from 2005 to 2011.
She also held the position of Head of Human Resources at Adnexus and Vice President of Human Resources at Kyruus, Inc. Ms. Regan completed her undergraduate degree at Clark University and her graduate degree at Suffolk University.
Postes actifs de Teresa Regan
| Sociétés | Poste | Début |
|---|---|---|
| NEON THERAPEUTICS, INC. | Human Resources Officer | 16/08/2017 |
Anciens postes connus de Teresa Regan
| Sociétés | Poste | Fin |
|---|---|---|
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | Human Resources Officer | 01/01/2011 |
| CUBIST PHARMACEUTICALS INC | Human Resources Officer | 01/01/2004 |
Kyruus, Inc.
 Kyruus, Inc. Packaged SoftwareTechnology Services Kyruus, Inc. provides physician network optimization software solutions. Its big data solutions helps hospitals and health systems optimize their patient access, referral management, and care coordination operations. The firm serves hospitals, health systems and accountable care organizations. The company was founded by Graham Gardner, Julie Keunhee Yoo and Vinay Seth Mohta in January 2010 and is headquartered in Boston, MA. | Human Resources Officer | - |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Human Resources Officer | - |
Formation de Teresa Regan
| Clark University | Undergraduate Degree |
| Suffolk University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | Health Technology |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Health Technology |
Kyruus, Inc.
Kyruus, Inc. Packaged SoftwareTechnology Services Kyruus, Inc. provides physician network optimization software solutions. Its big data solutions helps hospitals and health systems optimize their patient access, referral management, and care coordination operations. The firm serves hospitals, health systems and accountable care organizations. The company was founded by Graham Gardner, Julie Keunhee Yoo and Vinay Seth Mohta in January 2010 and is headquartered in Boston, MA. | Technology Services |
BioNTech US, Inc.
 BioNTech US, Inc. BiotechnologyHealth Technology BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA. | Health Technology |
